rrm2b-protein

RRM2B Protein (p53R2)

<div class="infobox infobox-protein">
| Property | Value |
|----------|-------|
| Protein Name | RRM2B (p53-Induced Ribonucleotide Reductase Small Subunit 2-like) |
| Gene | RRM2B |
| UniProt ID | Q7LG56 |
| Molecular Weight | ~37 kDa (353 aa) |
| Subcellular Localization | Mitochondria, nucleus |
| Protein Family | Ribonucleotide reductase small subunit family |
| Aliases | p53R2, R2, RRM2 |

</div>

Overview

The RRM2B protein (also known as p53R2 or ribonucleotide reductase small subunit 2-like) is a critical enzyme involved in deoxyribonucleotide (dNTP) synthesis and mitochondrial DNA maintenance. As a p53-regulated protein, RRM2B serves as a crucial link between DNA damage response, cellular stress signaling, and mitochondrial genome integrity. Mutations in RRM2B cause a spectrum of severe mitochondrial disorders characterized by early-onset neurodegeneration, muscle weakness, and progressive encephalomyopathy.

The protein functions as the small subunit of the ribonucleotide reductase (RNR) complex, which catalyzes the rate-limiting step in dNTP synthesis—the conversion of ribonucleotides to deoxyribonucleotides. Unlike the canonical RRM2 subunit, RRM2B is induced by p53 in response to DNA damage, providing a crucial mechanism for DNA repair and genome stability. This unique regulation positions RRM2B as a central node in cellular stress response and survival pathways.

Protein Structure and Function

Ribonucleotide Reductase Complex

RRM2B Protein (p53R2)

<div class="infobox infobox-protein">
| Property | Value |
|----------|-------|
| Protein Name | RRM2B (p53-Induced Ribonucleotide Reductase Small Subunit 2-like) |
| Gene | RRM2B |
| UniProt ID | Q7LG56 |
| Molecular Weight | ~37 kDa (353 aa) |
| Subcellular Localization | Mitochondria, nucleus |
| Protein Family | Ribonucleotide reductase small subunit family |
| Aliases | p53R2, R2, RRM2 |

</div>

Overview

The RRM2B protein (also known as p53R2 or ribonucleotide reductase small subunit 2-like) is a critical enzyme involved in deoxyribonucleotide (dNTP) synthesis and mitochondrial DNA maintenance. As a p53-regulated protein, RRM2B serves as a crucial link between DNA damage response, cellular stress signaling, and mitochondrial genome integrity. Mutations in RRM2B cause a spectrum of severe mitochondrial disorders characterized by early-onset neurodegeneration, muscle weakness, and progressive encephalomyopathy.

The protein functions as the small subunit of the ribonucleotide reductase (RNR) complex, which catalyzes the rate-limiting step in dNTP synthesis—the conversion of ribonucleotides to deoxyribonucleotides. Unlike the canonical RRM2 subunit, RRM2B is induced by p53 in response to DNA damage, providing a crucial mechanism for DNA repair and genome stability. This unique regulation positions RRM2B as a central node in cellular stress response and survival pathways.

Protein Structure and Function

Ribonucleotide Reductase Complex

RRM2B forms a heterodimeric complex with RRM1 (the large catalytic subunit) to constitute the complete ribonucleotide reductase enzyme:

• RRM1 (Large Subunit): Contains the catalytic site and allosteric regulatory domains, performing the actual reduction of ribonucleotides to deoxyribonucleotides.
• RRM2B (Small Subunit): Contains the diiron-carboxylate active site that generates a tyrosyl free radical essential for catalysis. The subunit is essential for stabilizing the RNR complex and maintaining enzymatic activity.

Structural Features

RRM2B contains several key structural elements:

• N-terminal Domain: Contains the diiron-carboxylate site essential for tyrosyl radical generation
• C-terminal Region: Mediates interaction with RRM1 and complex formation
• Iron-Sulfur Cluster: [2Fe-2S] center required for catalytic activity
• Nuclear Localization Signal: Facilitates import to nucleus for DNA repair functions

Enzymatic Activity

The primary enzymatic function of RRM2B is:

Normal Cellular Function

Mitochondrial DNA Maintenance

RRM2B is essential for maintaining mitochondrial DNA (mtDNA) integrity:

• mtDNA Replication: Provides dNTPs essential for mtDNA replication, particularly during repair and replication cycles
• mtDNA Repair: Supports base excision repair and other mtDNA repair pathways that require dNTP pools
• Mitochondrial Biogenesis: Maintains proper mtDNA copy number through balanced nucleotide provision
• Energy Metabolism: Proper mtDNA maintenance ensures oxidative phosphorylation capacity and cellular ATP production

DNA Damage Response

As a p53-regulated gene, RRM2B participates in the cellular response to DNA damage:

• p53-Dependent Induction: DNA damage triggers p53-mediated transcriptional activation of RRM2B
• DNA Repair Support: Provides dNTPs for repair synthesis during nucleotide excision repair, base excision repair, and homologous recombination
• Cell Cycle Checkpoint: Supports S-phase and G2/M checkpoint function through dNTP pool maintenance
• Genomic Stability: Prevents replication stress and DNA damage accumulation

Stress Response

RRM2B coordinates cellular responses to various stresses:

• Oxidative Stress: Increased dNTP pools support repair of oxidative DNA damage
• Replication Stress: Maintains replication fork progression and prevents fork collapse
• Metabolic Stress: Adapts dNTP synthesis to cellular energy status

Role in Neurodegeneration

Mitochondrial DNA Depletion Syndrome (MTDPS)

Biallelic mutations in RRM2B cause severe mitochondrial DNA depletion syndromes:

Clinical Features

• Early-Onset Encephalomyopathy: Progressive neurodegenerative disease presenting in infancy or early childhood
• Kearns-Sayre Syndrome: External ophthalmoplegia, cardiac conduction defects, cerebellar ataxia
• Progressive Muscle Weakness: Generalized myopathy with exercise intolerance
• Neurological Deterioration: Developmental regression, seizures, movement disorders
• Systemic Manifestations: Growth failure, hepatic dysfunction, renal involvement

Pathophysiology

• mtDNA Depletion: Reduced mtDNA copy number in muscle, brain, and other tissues
• dNTP Pool Imbalance: Altered nucleotide pools disrupt mtDNA replication
• Energy Failure: Impaired oxidative phosphorylation leads to cellular dysfunction
• Cell Death: Progressive loss of neurons and muscle cells

Parkinson's Disease

RRM2B deficiency contributes to PD pathogenesis through multiple mechanisms:

Mitochondrial Dysfunction

• Complex I Deficiency: Reduced mtDNA-encoded protein synthesis impairs respiratory chain
• Dopaminergic Neuron Vulnerability: High energy demands make these neurons particularly susceptible
• PINK1/Parkin Interaction: RRM2B deficiency may synergize with mitophagy defects
• Mitochondrial DNA Damage: Accumulated mutations in dopaminergic neurons

Evidence from Research

• Reduced RRM2B expression observed in PD substantia nigra
• RRM2B variants modify PD risk in some populations
• Animal models show RRM2B deficiency leads to dopaminergic neuron loss
• Oxidative stress in PD may impair RRM2B function

Therapeutic Implications

• Gene therapy approaches to restore RRM2B expression
• Small molecules to enhance RRM2B activity
• Antioxidant therapy to protect mitochondria
• Nucleotide supplementation strategies

Alzheimer's Disease

RRM2B may play a role in AD pathogenesis:

• Mitochondrial dysfunction is an early feature of AD
• RRM2B expression changes in AD brain
• DNA damage accumulation in AD neurons
• dNTP pool alterations may affect DNA repair

Aging and Cognitive Decline

Age-related decline in RRM2B function contributes to:

• Accumulated mtDNA mutations in neurons
• Impaired DNA repair capacity
• Cognitive decline associated with mitochondrial dysfunction
• Increased neuronal vulnerability to stress

Therapeutic Approaches

Gene Therapy

• AAV-Mediated Delivery: Viral vectors to deliver functional RRM2B to affected tissues
• CRISPR-Cas9 Correction: Editing of pathogenic mutations in patient cells
• Gene Replacement: Restoring RRM2B expression in targeted cell types

Small Molecule Activators

• RNR Enhancers: Compounds that increase RNR complex activity
• p53 Modulators: Agents that enhance p53-mediated RRM2B induction
• Iron-Sulfur Cluster Stabilizers: Protect the active site cofactor

Nucleotide Supplementation

• dNTP Precursors: Provide substrate support for DNA synthesis
• Ribonucleotide Reductase Boosters: Increase endogenous dNTP production
• Mitochondrial-Targeted Nucleotides: Direct delivery to mitochondria

Antioxidant Therapy

• Mitochondrial Protectants: Protect against oxidative damage
• Free Radical Scavengers: Reduce oxidative stress
• CoQ10 and Analogs: Support mitochondrial electron transport

Animal Models

| Model | Description | Phenotype |
|-------|-------------|-----------|
| Rrm2b Knockout | Complete gene deletion | Embryonic lethal |
| Rrm2b Heterozygous | Reduced expression | Mild mtDNA depletion |
| Conditional KO | Tissue-specific deletion | Muscle/neuron degeneration |
| Knock-in Mutations | Human pathogenic variants | Mitochondrial disease phenotype |

Biomarkers

Diagnostic Markers

• mtDNA Copy Number: Reduced in muscle and blood
• Serum Lactate: Elevated due to mitochondrial dysfunction
• Creatine Kinase: Elevated in myopathy
• CSF Biomarkers: Elevated neurofilament light chain

Therapeutic Monitoring

• mtDNA Levels: Track response to treatment
• dNTP Pools: Measure nucleotide levels
• Respiratory Chain Function: Assess mitochondrial activity

Research Directions

Current Questions

• What determines tissue-specific vulnerability in RRM2B deficiency?
• Can gene therapy achieve therapeutic benefit in human patients?
• What are the optimal strategies for nucleotide supplementation?
• How does RRM2B interact with other mitochondrial disease genes?

Emerging Areas

• CRPR-Based Therapies: Gene editing approaches
• Induced Pluripotent Stem Cells: Disease modeling and drug screening
• Mitochondrial DNA Base Editing: Direct correction of pathogenic mutations
• Combination Therapies: Multi-target approaches for complex diseases

See Also

• [RRM2B Gene](/genes/rrm2b)
• [Mitochondrial DNA Depletion Syndrome](/diseases/mitochondrial-dna-depletion)
• [Mitochondrial Dysfunction Pathway](/mechanisms/mitochondrial-dysfunction-pathway)
• [DNA Damage Response](/mechanisms/dna-damage-response)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Ribonucleotide Reductase](/mechanisms/dna-synthesis-pathway)

External Links

• [UniProt Q7LG56 - RRM2B](https://www.uniprot.org/uniprot/Q7LG56)
• [NCBI Gene: RRM2B](https://www.ncbi.nlm.nih.gov/gene/50484)
• [OMIM: 604712](https://www.omim.org/entry/604712)
• [GeneCards: RRM2B](https://www.genecards.org/cgi-bin/carddisp.pl?gene=RRM2B)

References